ESGO-ESHRE-ESGE guidelines for fertility-sparing treatment and follow-up in patients with cervical and ovarian cancer and borderline ovarian tumours

ESGO made the following post on X:

“Published last night in The Lancet Oncology.
Paper: ESGO-ESHRE-ESGE guidelines for fertility-sparing treatment & follow-up in patients with cervical & ovarian cancer & borderline ovarian tumours.

It is FREE to read with registration.

A heartfelt thank you to our peers at European Society of Human Reproduction and Embryology& European Society of Gynaecological Endoscopy for this collaboration!”

Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE

Authors: Prof. Philippe Morice, MD, Prof. Giovanni Scambia, MD, Prof. Nadeem R. Abu-Rustum, MD, Prof. Maribel Acien, MD, Alessandro Arena, MD, Prof. Sara Brucker, MD, Prof. Ying Cheong, MD, Prof. Pierre Collinet, MD, Francesco Fanfani, MD, Francesca Filippi, MD, Prof. Ane Gerda Zahl Eriksson, MD, Prof. Sebastien Gouy, MD, Prof. Philipp Harter, MD, Prof. Xavier Matias-Guiu, MD, George Pados, MD, Maja Pakiz, MD, Prof. Denis Querleu, MD, Prof. Alexandros Rodolakis, MD, Christine Rousset-Jablonski, MD, Artem Stepanyan, MD, Prof. Antonia Carla Testa, MD, Kirsten Tryde Macklon, MD, Dimitrios Tsolakidis, MD, Michel De Vos, MD, François Planchamp, MSc, Prof. Michaël Grynberg, MD

Source: ESGO/X